Illustrative image – not actual.Ranbaxy Laboratories plans to set up a new Rs.200 crore dosage manufacturing facility in a phased manner.
The exact location, capacity and investment in the plant and will be finalised by end-2007.
The facility, that is expected to be approved by the FDA, will supply products globally enabling Ranbaxy to meet worldwide product demand in the next three-five years, when the plant becomes operational.
